Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Buti

Showing results (141-150 of 386) with videos related to

Pageof 39
Sort By:
Transfusion|October 5, 2018
Thrombotic thrombocytopenic purpura relapse induced by acute hepatitis E transmitted by cryosupernatant plasma and successfully controlled with ribavirinMar Riveiro-Barciela, Marta Bes, Josep Quer, et al.
Expert Review of Vaccines|May 13, 2025
Toward elimination of hepatitis A and B in Europe: vaccination successes, challenges, and opportunitiesMaria Buti, Paolo Bonanni, Nimzing Ladep, et al.
Journal of Hepatology|February 27, 2010
Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analoguesJurriën G P Reijnders, Katja Deterding, Jörg Petersen, et al.
Journal of Hepatology|July 22, 2022
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paperThomas Marjot, Christiane S Eberhardt, Tobias Boettler, et al.
United European Gastroenterology Journal|April 27, 2022
Digestive cancer screening across EuropePatrizia Burra, Michael Bretthauer, Maria Buti Ferret, et al.
Scientific Reports|August 26, 2021
A novel model of care for simplified testing of HBV in African communities during the COVID-19 pandemic in SpainCamila A Picchio, Daniel K Nomah, Silvia G Araujo, et al.
BMC Gastroenterology|July 19, 2011
Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case seriesMònica Sabaté, Luisa Ibáñez, Eulàlia Pérez, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|June 3, 2015
Profiles and clinical management of hepatitis C patients in Spain: disHCovery studyMaria Buti, Alejandro Franco, Isabel Carmona, et al.
European Journal of Public Health|July 4, 2025
Blood-borne virus testing in European emergency departments: current evidence and service considerationsElizabeth Smout, Murad Ruf, Maria Buti, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic responseMaria Buti, Yoav Lurie, Natalia G Zakharova, et al.
Pageof 39

Showing results (141-150 of 386) with videos related to

Sort By:
Pageof 39
Transfusion|October 5, 2018
Thrombotic thrombocytopenic purpura relapse induced by acute hepatitis E transmitted by cryosupernatant plasma and successfully controlled with ribavirinMar Riveiro-Barciela, Marta Bes, Josep Quer, et al.
Expert Review of Vaccines|May 13, 2025
Toward elimination of hepatitis A and B in Europe: vaccination successes, challenges, and opportunitiesMaria Buti, Paolo Bonanni, Nimzing Ladep, et al.
Journal of Hepatology|February 27, 2010
Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analoguesJurriën G P Reijnders, Katja Deterding, Jörg Petersen, et al.
Journal of Hepatology|July 22, 2022
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paperThomas Marjot, Christiane S Eberhardt, Tobias Boettler, et al.
United European Gastroenterology Journal|April 27, 2022
Digestive cancer screening across EuropePatrizia Burra, Michael Bretthauer, Maria Buti Ferret, et al.
Scientific Reports|August 26, 2021
A novel model of care for simplified testing of HBV in African communities during the COVID-19 pandemic in SpainCamila A Picchio, Daniel K Nomah, Silvia G Araujo, et al.
BMC Gastroenterology|July 19, 2011
Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case seriesMònica Sabaté, Luisa Ibáñez, Eulàlia Pérez, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|June 3, 2015
Profiles and clinical management of hepatitis C patients in Spain: disHCovery studyMaria Buti, Alejandro Franco, Isabel Carmona, et al.
European Journal of Public Health|July 4, 2025
Blood-borne virus testing in European emergency departments: current evidence and service considerationsElizabeth Smout, Murad Ruf, Maria Buti, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic responseMaria Buti, Yoav Lurie, Natalia G Zakharova, et al.
Pageof 39